Publication	Data		Fish	Anatomy
Ding et al., 2022	Fig. 3		WT + CRISPR2-mtor	whole organism mtor expression decreased amount, abnormal
Kim et al., 2021	Figure 6		mtorxu015Gt/+ (WIK)	heart contraction decreased efficacy, abnormal
Chaturantabut et al., 2019	Fig. 4		mtorxu015Gt/xu015Gt	liver decreased size, abnormal
Ding et al., 2019	Fig. 5.		mtorxu015Gt/+	heart ab1-map1lc3 labeling increased amount, abnormal
Meireles et al., 2018	Fig. 1		mtorxu015Gt/xu015Gt (TL)	central nervous system central nervous system myelination decreased process quality, abnormal central nervous system oligodendrocyte mbpa expression decreased amount, abnormal embryo development delayed, abnormal peripheral nervous system myelinating Schwann cell mbpa expression decreased amount, abnormal peripheral nervous system myelination in peripheral nervous system decreased process quality, abnormal
He et al., 2017	Fig. 5		cq32Tg; cq33Tg + MO1-mtor ,   cq33Tg; jh1Tg + MO1-mtor ,   s854Tg + MO1-mtor ,   cq32Tg + MO1-mtor ,   jh1Tg + MO1-mtor	digestive system urb1 expression decreased amount, abnormal liver decreased size, abnormal liver DsRed expression amount, ameliorated liver DsRed expression decreased amount, abnormal liver size, ameliorated pancreas decreased size, abnormal pancreas EGFP expression amount, ameliorated pancreas EGFP expression decreased amount, abnormal pancreas size, ameliorated
Shen et al., 2016	Fig. 6		mtorxu015Gt/xu015Gt	trunk curved ventral, abnormal
Kearns et al., 2015	Fig. 2		mtorxu015Gt/xu015Gt	spinal cord central nervous system myelination decreased occurrence, abnormal spinal cord has fewer parts of type oligodendrocyte, abnormal spinal cord myelin sheath decreased thickness, abnormal spinal cord oligodendrocyte cldnk expression decreased amount, abnormal spinal cord oligodendrocyte mbpa expression decreased amount, abnormal spinal cord oligodendrocyte plp1a expression decreased amount, abnormal spinal cord oligodendrocyte ab1-mbp labeling decreased amount, abnormal whole organism dhrs12 expression decreased amount, abnormal whole organism fdps expression decreased amount, abnormal whole organism hmgcra expression decreased amount, abnormal whole organism hmgcs1 expression decreased amount, abnormal whole organism mbpa expression decreased amount, abnormal whole organism mpz expression decreased amount, abnormal whole organism cholesterol biosynthetic process decreased occurrence, abnormal
	Fig. 3		mtorxu015Gt/xu015Gt	spinal cord has fewer parts of type oligodendrocyte, abnormal spinal cord oligodendrocyte cldnk expression decreased amount, abnormal spinal cord oligodendrocyte mbpa expression decreased amount, abnormal spinal cord oligodendrocyte plp1a expression decreased amount, abnormal spinal cord oligodendrocyte ab1-mbp labeling decreased amount, abnormal
	Fig. 4		mtorxu015Gt/xu015Gt	whole organism ab1-rps6 labeling decreased amount, abnormal whole organism TOR signaling decreased occurrence, abnormal
Ding et al., 2011	Fig. 3		mtorxu015Gt/xu015Gt	cardiac muscle cell decreased size, abnormal cell proliferation involved in heart morphogenesis decreased occurrence, abnormal liver low brightness, abnormal whole organism decreased behavioural activity, abnormal whole organism decreased size, abnormal
	text only		mtorxu015Gt/xu015Gt	whole organism viability, abnormal
Makky et al., 2007	Fig. 7		WT + MO1-mtor	gut decreased size, abnormal gut endothelial cell morphology, abnormal gut epithelium morphology, abnormal intestine decreased size, abnormal liver decreased size, abnormal